In Lisbon, ESC Preventive Cardiology 2025 brings together experts dedicated to enhancing preventive measures in cardiology. Attendees will gain insights into evidence-based approaches, community health strategies, and innovative technologies improving patient outcomes. Our team will present research addressing key challenges in prevention and discuss collaboration opportunities to drive impactful solutions. Let’s meet to explore shared goals in advancing preventive care.
Richmond Pharmacology will attend JSCPT 2025 in Tokyo, represented by their leadership team. Topics include early-phase studies, bridging studies between Europe and Asia, gene and RNA-based therapy development, and cross-border collaboration.
By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
.svg){kind=small}
.avif)
